Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Circuit arrangement for a piezo transformer, and method therefor
Rose plant named `ESM R044`
Registration and network access control
Hemostatic devices and methods of making same
Modulators of cystic fibrosis transmembrane conductance regulator
Electric vehicle charging station parking meter systems
Traffic flow analysis mitigation using a cover signal
  Randomly Featured Patents
Algorithm to drive semiconductor laser diode
Passive keyless entry system
Marine impeller tester
Belt hanger
Extended release growth promoting two component composition
Apparatus for transferring material between conveyors
Multistage hydraulic machines having air exhausting devices
Flavoring compositions containing mixture of 2,2,6-trimethyl-1-cyclohexen-1-ylacetaldehyde and 2,6,6-trimethyl-1-crotonyl-1,3-cyclohexadiene
Pull chain lampholders for mounting upon outlet boxes
Treatment of paper for improved electrostatographic fusing